FUND PARTICIPATION AGREEMENT
THIS AGREEMENT is entered into as of this ____day of _________ 2008
among MetLife Investors USA Insurance Company, ("Insurance Company"), on behalf
of itself and certain of its separate accounts; Met Investor Series Trust (
"Trust"); AMERICAN FUNDS INSURANCE SERIES ("Series"), an open-end management
investment company organized under the laws of the Commonwealth of
Massachusetts; and CAPITAL RESEARCH AND MANAGEMENT COMPANY ("CRMC"), a
corporation organized under the laws of the State of Delaware.
WITNESSETH:
WHEREAS, Insurance Company has issued and proposes to issue, now and in
the future, certain variable annuity contracts and/or variable life policies
(the "Contracts");
WHEREAS, Insurance Company has established pursuant to applicable
insurance law one or more separate accounts (each, an "Account") for purposes of
issuing the Contracts and has or will register each Account (unless the Account
is exempt from such registration) with the United States Securities and Exchange
Commission (the "Commission") as a unit investment trust under the Securities
Act of 1933 (the "1933 Act") and the Investment Company Act of 1940 (the "1940
Act");
WHEREAS, the Contracts, which are or will be registered by Insurance
Company (unless exempt from such registration) with the Commission for offer and
sale;
WHEREAS, the Series has received a "Mixed and Shared Funding Order"
from the Commission granting relief from certain provisions of the 1940 Act and
the rules thereunder to the extent necessary to permit shares of the Series to
be sold to variable annuity and life insurance separate accounts of unaffiliated
insurance companies;
WHEREAS, the Series is divided into various funds (the "Master Funds"),
and each Master Fund is subject to certain fundamental investment policies which
may not be changed without a majority vote of the shareholders of such Master
Fund;
WHEREAS, the Trust is divided into various series (the "Portfolios"),
and each Portfolio has its own assets and liabilities and invests in securities
in accordance with its investment objectives and policies, as described in the
registration statement for the Portfolios;
WHEREAS, certain Portfolios propose to hold as their only investment
shares of a corresponding Master Fund as set forth in Attachment A, as such
Appendix A may be amended from time to time by mutual agreement in writing, with
each such Portfolio having the same investment objective and compatible
fundamental investment restrictions and policies as the corresponding Master
Fund as described in the registration statement for the Master Fund;
WHEREAS, certain Master Funds (through the Portfolios) listed in
Attachment A to this Agreement will serve as certain of the underlying
investment mediums for the Contracts issued with respect to the Accounts; and
WHEREAS, CRMC is the investment adviser for the Series.
NOW, THEREFORE, in consideration of the foregoing and of mutual
covenants and conditions set forth herein and for other good and valuable
consideration, Insurance Company, the Trust, the Series and CRMC hereby agree as
follows:
1. The Series and CRMC each represents and warrants to Insurance
Company and the Trust that: (a) a registration statement under the 1933 Act and
under the 1940 Act (collectively, the "SEC Filings") with respect to the Series
has been filed with the Commission in the form previously delivered to Insurance
Company and the Trust, and copies of any and all amendments thereto will be
forwarded to Insurance Company and the Trust at the time that they are filed
with the Commission; (b) the Series is, and shall be at all times while this
Agreement is in force, lawfully organized, validly existing, and properly
qualified as an open-end management investment company in accordance with the
laws of the Commonwealth of Massachusetts; (c) the Series' registration
statement and any further amendments thereto will, when they become effective,
and all definitive prospectuses and statements of additional information and any
further supplements thereto (the "Prospectus") shall, conform in all material
respects to the requirements of the 1933 Act and the 1940 Act and the rules and
regulations of the Commission thereunder, and will not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statement therein not misleading;
provided, however, that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Series by Insurance Company and the Trust expressly
for use therein; and (d) the Series and CRMC will comply in all material
respects with all applicable laws and regulations, including, without
limitation, the 1933 Act and the 1940 Act and the rules and regulations
thereunder.
2. The Trust represents and warrants to the Series and CRMC that (a) the shares
of the Portfolios are or will be registered under the 1933 Act and that the
shares will be issued, sold and distributed in compliance in all material
respects with all applicable federal securities laws; (b) the Trust is, and
shall be at all times while this Agreement is in force, lawfully organized and
validly existing under the laws of Delaware; (c) the Trust is and shall remain
at all times while this Agreement is in force, registered as an open-end
management investment company under the 1940 Act; (d) the SEC Filings (including
the registration statement) of the Trust conform or, when they become effective,
will conform in all material respects to the requirements of the 1933 Act and
the 1940 Act, and the rules and regulations of the Commission thereunder, and
will not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading; provided, however, that this representation and warranty
shall not apply to any statements or omissions made in reliance upon and in
conformity with information furnished in writing to the Trust by CRMC or the
Series expressly for use therein; and (e) the Trust will comply in all material
respects with all applicable laws and regulations, including, without
limitation, the 1933 Act and the 1940 Act and the rules and regulations
thereunder.
3. Insurance Company represents and warrants to the Series and CRMC that the
Contracts are or will be and at the time of issuance will be treated as annuity
contracts and life insurance policies, as applicable, under applicable
provisions of the Internal Revenue Code of 1986, as amended, and the regulations
thereunder (the "Code"), that it will maintain such treatment and that it will
notify the Series and CRMC immediately upon having a reasonable basis for
believing that the Contracts have ceased to be so treated or that they might not
be so treated in the future. The Insurance Company further represents and
warrants to AFD and CRMC that:
a. a registration statement under the 1933 Act and under the 1940 Act
(if required by law) with respect to the Contracts and each Account has
been or will be filed with the Commission (a copy of which will be
delivered to AFD, upon request, when effective), and copies of any and
all amendments thereto will be forwarded to AFD, upon request, at the
time that they are filed with the Commission (if required by law);
b. each such registration statement (if required by law) and any
further amendments or supplements thereto will, when they become
effective, conform in all material respects to the requirements of the
1933 Act and the 1940 Act, and the rules and regulations of the
Commission thereunder, and will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading;
provided, however, that this representation and warranty shall not
apply to any statement or omission made in reliance upon and in
conformity with the information furnished in writing to Insurance
Company or the Distributor by AFD or CRMC expressly for use therein;
4. (a) The Series will furnish to Insurance Company and the Trust such
information with respect to the Series in such form and signed by such
of its officers as Insurance Company and the Trust may reasonably
request, and will warrant that the statements therein contained when so
signed will be true and correct. The Series will advise Insurance
Company and the Trust immediately of: (1) the issuance by the
Commission of any stop order suspending the effectiveness of the
registration statement of the Series or the initiation of any
proceeding for that purpose; (2) the institution of any proceeding,
investigation or hearing involving the offer or sale of the Contracts
or the Series of which it becomes aware; or (3) the happening of any
material event, if known, which makes untrue any statement made in the
registration statement of the Series or which requires the making of a
change therein in order to make any statement made therein not
misleading.
(b) The Series will use best efforts to register for sale under the
1933 Act and, if required, under state securities laws, such additional
shares of the Series as may reasonably be necessary for use as the
funding vehicle for the Contracts.
5. The Series agrees to make Class 1 shares of the Master Funds listed
on Attachment A hereto available to the Portfolios. Master Fund shares
to be made available to Accounts for the Contracts (through the
Portfolios) shall be sold by the Series and purchased by the Trust for
a given Account at the net asset value of the respective class of the
respective Master Fund (without the imposition of a sales load) next
computed after receipt of each order by the Series or its designee, as
established in accordance with the provisions of the then current
Prospectus of the Series.
For purposes of this Paragraph 5, Insurance Company shall be a designee
of the Trust and the Series for receipt of such orders from each Account, and
receipt by such designee by 4:00 p.m. Eastern time (or other such time the Board
of Trustees of the Series shall so designate) shall constitute receipt by both
the Trust and the Series; provided that the Trust and the Series each receive
notice of such order by 9:30 a.m. Eastern time on the following Business Day
("Next Business Day"). "Business Day" shall mean any day on which the New York
Stock Exchange ("NYSE") is open for trading and on which the Series calculates
the net asset values of each class of shares of each Master Fund pursuant to the
rules of the Commission. The Series will make the Class 1 shares of each Master
Fund available indefinitely for purchase at the applicable net asset value per
share by the Trust and the Accounts (through the Portfolios) on those days on
which the Series calculates the net asset values of each such class pursuant to
the rules of the Commission, and the Series shall use its best efforts to
calculate such net asset values on each day on which the NYSE is open for
trading. The Series shall make the net asset value per share for Class 1 shares
of each Master Fund available to the Trust on a daily basis as soon as
reasonably practical after the Series calculates such net asset values per
share, and the Series shall use its best efforts to make such net asset values
per share available by 6:30 p.m. Eastern time. CRMC and the Series shall report
to the Trust and Insurance Company any material error in the calculation of the
net asset values, dividends or capital gain information as soon as practicable
upon discovery. The Series and CRMC are responsible for maintaining net asset
values for each class of each Master Fund in accordance with the requirements of
the 1940 Act and the Series' then current Prospectus. Payments for shares
purchased will be made in federal funds transmitted by wire on the Next Business
Day, and the Trust and the Series shall each use commercially reasonable efforts
to wire (or cause to be wired) funds to the other, for the purpose of settling
net purchase orders or orders of redemption, by 3:00 p.m. Eastern time on the
Next Business Day.
The Series reserves the right to temporarily suspend sales if the Board
of Trustees of the Series, acting in good faith and in light of its fiduciary
duties under federal and any applicable state laws, deems it appropriate and in
the best interests of shareholders or in response to the order of an appropriate
regulatory authority. Further, the Series reserves the right to reject any
purchase order if, in the opinion of the officers of the Series or CRMC, the
trading activities of any Contract owner, through the Trust, is or potentially
may be harmful to the Series.
Insurance Company and the Trust have policies and procedures in place
to detect and discourage short-term or disruptive trading practices, which may
include (but is not limited to) monitoring Contract holder trading activity.
Insurance Company and the Trust reserve the right to refuse, to impose
limitations on, or to limit any transaction request if the request would tend to
disrupt Contract administration or is not in the best interest of the Contract
holders or an Account or subaccount thereof.
6. The Trust will make shares of the Portfolios listed on Appendix A
available only to Insurance Company, its insurance company affiliates, and their
respective separate accounts and to pension plans and will register for sale
under the 1933 Act and, if required, under state securities laws, such
additional shares of the Portfolios as may reasonably be necessary for use as
the funding vehicle for the Contracts and to maintain a continuous offering of
the shares of the Portfolios.
7. The Contracts funded through each Account will provide for the
allocation of net amounts among certain subaccounts corresponding to the Class 1
shares of each Master Fund (each, a "Subaccount") for investment in shares of
the Portfolios as may be offered from time to time in the Contracts. The
selection of the particular Subaccount is to be made by the Contract owner in
accordance with the terms of the Contracts and such selection may be changed in
accordance with the terms of the Contracts.
8. Transfer of the Series' shares will be by book entry only. No stock
certificates will be issued to the Portfolios. Shares ordered from a particular
Master Fund will be recorded by the Series as instructed by the Trust in an
appropriate title for the corresponding Portfolio. Shares ordered from a
particular Portfolio will be recorded by the Trust or the Trust's transfer agent
as instructed by Insurance Company in an appropriate title for the corresponding
Account or its subaccount.
9. The Series shall furnish notice promptly to the Trust of any
dividend or distribution payable on any shares of the Master Funds held by the
Portfolios. The Trust hereby elects to receive all such dividends and
distributions as are payable on shares of a Master Fund recorded in the title
for the corresponding Portfolio in additional shares of that Master Fund. The
Series shall notify the Trust of the number of shares so issued. The Trust
reserves the right to revoke this election and to receive all such income
dividends and capital gain distributions in cash.
10. The Series shall effect redemptions of interests in the Master
Funds in accordance with the terms of the Master Funds' then current Prospectus
and the provisions of the 1940 Act and the rules and regulations thereunder. For
purposes of this Paragraph 9, Insurance Company shall be a designee of each
Portfolio and each Master Fund for receipt of requests for redemption from each
Account, and receipt by such designee by 4:00 p.m. Eastern time (or other such
time the Boards of Trustees of the Trust and the Series shall so designate)
shall constitute receipt by the Trust and the Series; provided that the Trust or
Series each receives actual notice of such request for redemption by 9:30 a.m.
Eastern time on the Next Business Day. Insurance Company shall purchase and
redeem the shares of the Portfolios offered by the then current Prospectus of
the Trust in accordance with the provisions of such Prospectus.
11. The Series shall pay all expenses incidental to its performance
under this Agreement. The Series shall see to it that all of its shares are
registered and authorized for issue in accordance with applicable federal and
state laws prior to their purchase by the Trust for an Account. The Series shall
bear the expenses for the cost of registration of its shares, preparation of
prospectuses (and supplements thereto) and statements of additional information
to be sent to existing Contract owners (upon request in the case of the
statement of additional information), proxy statements and related materials and
annual and semi-annual shareholder reports, the printing and distribution of
such items to each Contract owner who has allocated net amounts to any
subaccount, the preparation of all statements and notices required from it by
any federal or state law, and taxes on the issue or transfer of the Series'
shares subject to this Agreement. The Series will provide Insurance Company, at
least once a year, with enough copies of its Statement of Additional Information
to be able to distribute one to each Contract owner or prospective Contract
owner who requests such Statement of Additional Information.
With respect to any prospectus and annual and semi-annual reports (the
"Reports") of the Series that are printed in combination with any one or more
such Reports of other investment options for the Contracts (the "Booklet"), the
Series shall bear the costs of printing and mailing the Booklet to existing
Contract owners based on the ratio of the number of pages of the Series' Reports
included in the Booklet to the number of pages in the Booklet as a whole.
12. Insurance Company shall bear the expenses for the cost of
preparation and delivery of Series prospectuses (and supplements thereto) to be
sent to prospective Contract owners. The Series shall provide, at its expense,
such documentation (in camera-ready or other mutually agreeable form) and other
assistance as is reasonably necessary in order for Insurance Company once each
year (or more frequently if the prospectus for the Series is amended), and twice
each year in the case of the annual and semi-annual shareholder reports, to have
the prospectus or prospectuses, and the annual and semi-annual shareholder
reports for the Contracts and the Series, printed together in one or more
documents (such printing to be done at Insurance Company's expense with respect
to prospective investors).
13. Insurance Company and the Trust each represent and warrant to the
Series that any information furnished in writing by Insurance Company or the
Trust, respectively, to the Series for use in the registration statement of the
Series will not result in the registration statement's failing to conform in all
respects to the requirements of the 1933 Act and the 1940 Act and the rules and
regulations thereunder or containing any untrue statement of a material fact or
omission to state a material fact required to be stated therein or necessary to
make the statements therein not misleading.
The Series represents and warrants to Insurance Company and
the Trust that any information furnished in writing by the Series to Insurance
Company or the Trust for use in the registration statement of the Trust or
Insurance Company will not result in the registration statement's failing to
conform in all respects to the requirements of the 1933 Act and the 1940 Act and
the rules and regulations thereunder or containing any untrue statement of a
material fact or omission to state a material fact required to be stated therein
or necessary to make the statements therein not misleading.
14. Insurance Company, the Trust and their affiliates shall make no
representations concerning the Series' shares except those contained in the then
current Prospectus of the Series, current statement of additional information of
the Series, in such printed information subsequently issued on behalf of the
Series or other funds managed by CRMC as supplemental to the Series' Prospectus,
in information published on the Series' or CRMC's internet site, or in materials
approved by CRMC or its affiliates. Likewise, Series and CRMC and their
affiliates shall make no representations concerning the Trust's shares except
those contained in the then current Prospectus of the Trust, current statement
of additional information of the Trust, in such printed information subsequently
issued on behalf of the Trust, in information published on the Trust's or its
investment manager's internet site, or in materials approved by the Trust's
investment manager or its affiliates
15. Shares of the Series may be offered to separate accounts of various
insurance companies in addition to Insurance Company. The Series represents,
warrants and covenants that no shares of the Series shall be sold to the general
public in contravention of Section 817 of the Internal Revenue Code of 1986, as
amended, and the regulations thereunder (the "Code"). The Series agrees that
each Master Fund will comply with the diversification requirements of Section
817. The Series also agrees to maintain each Master Fund's qualification as a
"regulated investment company" ("RIC") under the Code.
16. The parties to this Agreement recognize that due to differences in
tax treatment or other considerations, the interests of various Contract owners
participating in one or more of the Portfolios or Master Funds might, at some
time, be in conflict. Each party shall report to the other party any potential
or existing conflict of which it becomes aware. The Board of Trustees of the
Series shall promptly notify Insurance Company and the Trust of the existence of
irreconcilable material conflict and its implications. If such a conflict
exists, Insurance Company will, at its own expense, take whatever action it
deems necessary to remedy such conflict; in any case, Contract owners will not
be required to bear such expenses.
The Series hereby notifies Insurance Company and the Trust that it may
be appropriate to include in the Prospectus pursuant to which a Contract is
offered disclosure regarding the risks of mixed and shared funding.
17. Insurance Company agrees to indemnify and hold the Series and CRMC
harmless against any and all losses, claims, damages, liabilities or litigation
(including reasonable legal and other expenses) to which the Series or CRMC may
be subject under any statute, at common law or otherwise, insofar as such
losses, claims, damages, liabilities or expenses (or actions in respect thereof)
or settlements arising as a result of Insurance Company's: (a) making untrue
statements of material facts or omitting material facts in a Contract's
registration statement, prospectus, statement of additional information, annual
reports to Contract owners and sales literature for the Contracts; (b) making
untrue statements of material facts that the Series or CRMC includes in the same
materials of the Series, provided that Series or CRMC relies on information
supplied by Insurance Company; (c) unlawful conduct, bad faith, willful
malfeasance, or gross negligence by Insurance Company with respect to the sale
of the Contracts or Portfolio or Master Fund shares; and (d) breaching this
Agreement or a representation or warranty.
18. The Trust agree to indemnify and hold the Series and CRMC harmless
against any and all losses, claims, damages, liabilities or litigation
(including reasonable legal and other expenses) to which the Series or CRMC may
be subject under any statute, at common law or otherwise, insofar as such
losses, claims, damages, liabilities or expenses (or actions in respect thereof)
or settlements arising as a result of the Trust's: (a) making untrue statements
of material facts or omitting material facts in the Trust's registration
statement, prospectus, statement of additional information, semi-annual or
annual reports provided to Contract owners and in sales literature for the
Trust; (b) making untrue statements of material facts that the Series or CRMC
includes in the same materials of the Series, provided that Series or CRMC
relies on information supplied by the Trust; (c) unlawful conduct, bad faith,
willful malfeasance, or gross negligence by the Trust with respect to the sale
of Portfolio shares; and (d) materially breaching this Agreement or a
representation or warranty.
19. The Series and CRMC each agrees to indemnify and hold Insurance
Company and the Trust harmless against any and all losses, claims, damages,
liabilities or litigation (including reasonable legal and other expenses) to
which the Insurance Company or the Trust may be subject under any statute, at
common law or otherwise, insofar as such losses, claims, damages, liabilities or
expenses (or actions in respect thereof) or settlements arising as a result of
the Series', or CRMC's: (a) making untrue statements of material facts or
omitting material facts in the Series' registration statement, prospectuses or
statements of additional information, semi-annual and annual reports to
shareholders, and sales literature; (b) making untrue statements of material
facts that the Insurance Company or the Trust includes in their materials,
provided the Insurance Company or the Trust relies on information supplied by
the Series; (c) unlawful conduct, bad faith, willful malfeasance, or gross
negligence by the Series with respect to the sale of the Contracts, Portfolio or
Master Fund shares or the operation of the Series or a Master Fund; (d) failure
of the Series to comply with any Master Fund's investment objectives, policies
and restrictions; and (e) materially breaching this Agreement or a
representation or warranty, including, but not limited to, the representations,
warranties and covenants in Section 14.
20. Insurance Company shall be responsible for assuring that the
Account calculates pass-through voting privileges of Contract owners in a manner
consistent with the method of calculating pass-through voting privileges set
forth in the current Contract or the prospectus for the Contract. The Series and
CRMC will comply in all material respects with all of the provisions of the 1940
Act requiring voting by shareholders.
21. The parties understand that there is no intention to create a joint
venture in the subject matter of this Agreement. Accordingly, the right to
terminate this Agreement and to engage in any activity not inconsistent with
this Agreement is absolute. This Agreement will terminate:
(a) by mutual agreement at any time; or
(b) any party at any time upon sixty days' written notice to the other
parties; or
(c) at the option of Insurance Company, the Trust, CRMC or the Series upon
ten calendar days' prior written notice to the other party if a final
non-appealable administrative or judicial decision is entered against
the other party which has a material impact on the Contracts; or
(d) at the option of Insurance Company or the Trust, upon ten calendar
days' prior written notice, if shares of the Series are not reasonably
available; or
(e) at the option of Insurance Company or the Trust, immediately upon
written notice, if the Series or CRMC fails to meet the requirements
for either diversification under Section 817 or RIC status under the
Code;or
(f) in the event the Series' shares are not registered, issued or sold in
accordance with applicable state and/or federal law or such law
precludes the use of such shares as an underlying investment for the
Porfolios or the Contracts issued or to be issued by Insurance
Company; in such event prompt notice shall be given by Insurance
Company, the Trust or the Series to each of the other parties; or
(g) at Insurance Company's or Trust's option by written notice to the
Series and/or CRMC if either shall determine in its sole judgment
exercised in good faith, that either the Series or CRMC has suffered a
material adverse change in its business, operations, financial
condition or prospects since the date of this Agreement or is the
subject of material adverse publicity; or
(h) at the option of the Series or CRMC by written notice to Insurance
Company and the Trust if the Series or CRMC shall determine in its
sole judgment exercised in good faith, that Insurance Company or the
Trust has suffered a material adverse change in its business,
operations, financial condition or prospects since the date of this
Agreement or is the subject of material adverse publicity.
The effective date for termination pursuant to any notice given under
this Paragraph shall be calculated beginning with the date of receipt of such
notice.
22. All notices, consents, waivers, and other communications under this
Agreement must be in writing, and will be deemed to have been duly received: (a)
when delivered by hand (with written confirmation of receipt); (b) when sent by
telecopier (with written confirmation of receipt), provided that a copy is
mailed by registered mail, return receipt requested; or (c) the day after it is
sent by a nationally recognized overnight delivery service, in each case to the
appropriate addresses and telecopier numbers set forth below (or to such other
addresses and facsimile numbers as a party may designate by notice to the other
parties):
If to Insurance Company:
MetLife Investors USA Insurance Company
0 Xxxx Xxxxx, Xxxxx 0000
Xxxxxx XX, 00000
Attention: President
with a copy to:
Xxxxxxx X. Xxxxxxx
Vice President, and Associate General Counsel
MetLife Investors USA Insurance Company
0 Xxxx Xxxxx, Xxxxx 0000
Xxxxxx XX, 00000
If to the Trust:
Met Investors Series Trust
0 Xxxx Xxxxx, Xxxxx 0000
Xxxxxx XX, 00000
Attention: President
With a Copy to
Met Investors Advisory LLC
000 Xxxxxxxx
Xxxxxx, XX
Attention: Xxxx Xxxxxxxxxx
If to Series:
American Funds Insurance Series
000 X. Xxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxxxx X. Xxxxxx, Senior Vice President
Facsimile No.: (000) 000-0000
with a copy to:
Capital Research and Management Company
000 X. Xxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxxxx X. Xxxxxxxxxx, Vice President and Senior Counsel,
Fund Business Management Group
Facsimile No.: (000) 000-0000
If to CRMC:
Capital Research and Management Company
000 X. Xxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxxxxx, XX 00000
Attention: Xxxxxxx X. Xxxxxx, Senior Vice President and Legal Counsel,
Fund Business Management Group, and Secretary
Facsimile No.: (000) 000-0000
with a copy to:
Capital Research and Management Company
000 X. Xxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxxxx X. Xxxxxxxxxx, Vice President and Senior Counsel,
Fund Business Management Group
Facsimile No.: (000) 000-0000
23. If this Agreement terminates, any provision of this Agreement
necessary to the orderly windup of business under it will remain in effect as to
that business, after termination.
24. If this Agreement terminates, the Series, at Insurance Company's
option, will continue to make additional shares of the Series available to the
Portfolios for all existing Contracts as of the effective date of termination
(under the same terms and conditions as were in effect prior to termination of
this Agreement with respect to existing Contract owners), unless the Series
liquidates or applicable laws prohibit further sales. Insurance Company agrees
not to redeem shares of the Series unless: (a) the Agreement is terminated; (b)
legitimately required to do so according to a Contract owner's request; (c)
under an order from the Commission or pursuant to exemptive relief granted by
the Commission or pursuant to a vote of Contract owners; (d) as otherwise agreed
to or permitted among the parties; or (e) unless Insurance Company or the Trust
provides at least sixty (60) days advance written notice.
25. The obligations of the Series under this Agreement are not binding
upon any of the Trustees, officers, employees or shareholders (except CRMC if it
is a shareholder) of the Series individually, but bind only the Series' assets.
When seeking satisfaction for any liability of the Series in respect of this
Agreement, the Trust, Insurance Company and the Account agree not to seek
recourse against said Trustees, officers, employees or shareholders, or any of
them, or any of their personal assets for such satisfaction. Notwithstanding the
foregoing, if Insurance Company or the Trust seek satisfaction for any liability
of the Series in respect of this Agreement, Insurance Company (on behalf of
itself or any Account) and/or the Trust may seek recourse against CRMC.
The obligations of the Trust under this Agreement are not binding upon
any of the Trustees, officers, employees or shareholders of the Trust
individually, but bind only the Trust's assets. When seeking satisfaction for
any liability of the Trust in respect of this Agreement, the Series and CRMC
agree not to seek recourse against said Trustees, officers, employees or
shareholders, or any of them, or any of their personal assets for such
satisfaction. Notwithstanding the foregoing, if the Series or CRMC seek
satisfaction for any liability of the Trust in respect of this Agreement, the
Trust may seek recourse against its investment adviser.
26. This Agreement shall be construed in accordance with the laws of
the Commonwealth of Massachusetts.
27. This Agreement and the parties' rights, duties and obligations
under this Agreement are not transferable or assignable by any of them without
the express, prior written consent of the other parties hereto. Any attempt by a
party to transfer or assign this Agreement or any of its rights, duties or
obligations under this Agreement without such consent is void; provided,
however, that a merger of, reinsurance arrangement by, or change of control of a
party shall not be deemed to be an assignment for purposes of this Agreement.
28. The following Paragraphs shall survive any termination of this
Agreement: 5,11, 12, 15, 17, 18, 19, and 22 to 28.
29. This Agreement and any amendment to it may be executed in one or
more counterparts. All of those counterparts shall constitute one and the same
agreement.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed and attested as of the date first above written.
METLIFE INVESTORS USA INSURANCE COMPANY
Attest:
By: _______________________________
___________________________ Its:
MET INVESTORS SERIES TRUST
Attest:
By: _______________________________
___________________________ Its:
AMERICAN FUNDS INSURANCE SERIES
Attest:
By: _______________________________
___________________________ Its: Secretary
CAPITAL RESEARCH AND MANAGEMENT COMPANY
Attest:
By: _______________________________
___________________________ Its: Vice President and Secretary
Attachment A
Master Funds and Corresponding Portfolios
------------------------------------------------------------ ---------------------------------------------------------
American Funds Insurance Series Master Funds:- Trust Portfolios:
------------------------------------------------------------ ---------------------------------------------------------
------------------------------------------------------------ ---------------------------------------------------------
|-| |-|
------------------------------------------------------------ ---------------------------------------------------------
------------------------------------------------------------ ---------------------------------------------------------
|-| |-|
------------------------------------------------------------ ---------------------------------------------------------
------------------------------------------------------------ ---------------------------------------------------------
|-| |-|
------------------------------------------------------------ ---------------------------------------------------------
------------------------------------------------------------ ---------------------------------------------------------
|-| |-|
------------------------------------------------------------ ---------------------------------------------------------
